News & Updates
Filter by Specialty:
Objective response to systemic therapy linked to overall survival in unresectable HCC
23 Jan 2023
byStephen Padilla
Objective response to first-line systemic therapy with lenvatinib or sorafenib independently predicts overall survival (OS) in individuals with unresectable hepatocellular carcinoma (HCC), as shown by the subanalysis of the REFLECT study.
Objective response to systemic therapy linked to overall survival in unresectable HCC
23 Jan 2023Multiple moles, genetic predisposition up risk of second primary melanomas
22 Jan 2023
Individuals with multiple nevi and high genetic predisposition to melanoma appear to have the highest risks of developing second primary melanomas, according to a study.
Multiple moles, genetic predisposition up risk of second primary melanomas
22 Jan 2023ADHD medication use carries no excess cardiovascular disease risk
22 Jan 2023
Attention-deficit/hyperactivity disorder (ADHD) medications do not appear to put users at increased risk of cardiovascular disease (CVD), although a modest risk increase for cardiac arrest or tachyarrhythmias cannot be ruled out, according to the results of a meta-analysis.